The Wuxi National Hi-Tech District (WND) has welcomed the opening of a new synthetic biology industrial park, marking a significant step forward for the region’s bio-industry. Within this park, Hunan Norchem Pharmaceutical Co., Ltd is preparing to establish the inaugural synthetic biology research and development center in East China, reinforcing the company’s commitment to innovation in the field.
Norchem has outlined plans to collaborate with Jiangnan University on the research and development of novel biological products. Since its establishment in 2013, Norchem has been recognized as the first high-tech enterprise in China to prepare steroidal drug intermediates and active pharmaceutical ingredients (APIs) using phytosterols as the starting material. The company’s growth has been supported by a Series B funding round in December of the previous year, which saw investments from prominent financial backers such as OrbiMed Advisors and the AZ-CICC Fund.- Flcube.com
